Legal Representation
Attorney
Richard W. Young
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 1, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Oct 1, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Mar 3, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 2, 2012 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Mar 1, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 1, 2012 | EXT5 | S | SOU EXTENSION 5 FILED |
| Sep 8, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 7, 2011 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Sep 1, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 1, 2011 | EXT4 | S | SOU EXTENSION 4 FILED |
| Apr 28, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 27, 2011 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Apr 25, 2011 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
| Apr 25, 2011 | PETG | O | PETITION TO REVIVE-GRANTED |
| Apr 25, 2011 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Mar 11, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 11, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Mar 10, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Mar 1, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 1, 2011 | LEXT | S | LATE FILED EXTENSION REQUEST |
| Mar 1, 2011 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Mar 1, 2011 | EXT3 | S | SOU EXTENSION 3 FILED |
| Sep 1, 2010 | EXT2 | S | SOU EXTENSION 2 FILED |
| Mar 1, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 1, 2010 | EXT1 | S | SOU EXTENSION 1 FILED |
| Mar 1, 2010 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Mar 1, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 1, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 9, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 20, 2009 | NPUB | O | NOTICE OF PUBLICATION |
| May 7, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Apr 30, 2009 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 30, 2009 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Apr 30, 2009 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Apr 30, 2009 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Apr 30, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 1, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 1, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 1, 2008 | CNFR | R | FINAL REFUSAL WRITTEN |
| Dec 1, 2008 | GNFR | O | FINAL REFUSAL E-MAILED |
| Dec 1, 2008 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Nov 26, 2008 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Nov 26, 2008 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Nov 26, 2008 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Nov 26, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 6, 2008 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Nov 6, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 6, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 11, 2008 | CNSI | R | SUSPENSION INQUIRY WRITTEN |
| Jun 11, 2008 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; astringents, anti-bacterial, anti-viral, anti-fungal, antibiotic and anti-allergic pharmaceuticals, pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of ear diseases and conditions; pharmaceutical preparations for the treatment of throat diseases and conditions; pharmaceutical preparations for the treatment of nose diseases and conditions; pharmaceutical preparations for the treatment of nail diseases and conditions; medicated hair care preparations; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology, ophthalmology and for gastroenterological disorders; sanitary preparations for medical purposes; dietetic foods adapted for medical use; dietetic substances adapted for medical use, namely, herbal supplements and extracts; food for babies; medical plasters, materials for wound dressings; disinfectants for sanitary purposes; antiseptics; disinfectants for contact lenses; solutions for use with contact lenses; dental preparations and materials, namely, medicated toothpastes, mouthwashes and flosses; dental preparations and materials, namely, rinses, polishes, waxes, adhesives, bonding and priming materials, fixatives, abrasives, alloys, amalgams and cements; medicated confectionery; foot care products, namely, medicated foot powder, lotions, creams, sprays and powders for use in the treatment of athletes' foot and other conditions of the feet; personal hygiene products, namely, feminine hygiene products, namely, feminine hygiene pads, towels and tampons; insect repellents; nutritional additives for use in foods and dietary supplements for human consumption; tissues, pads and wipes impregnated with pharmaceutical preparations
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005